Xceleron names president and CEO

Colin Garner, founder of Xceleron is retiring from the president/CEO position and will now serve as the senior scientific advisor to Xceleron and a non-executive director.

Mr Butler brings to Xceleron a balance of sales, operations and management know-how, including significant experience in expanding science-driven businesses.

Prior to joining Xceleron, Dr Butler served as president and chief scientific officer at Aptuit, a global pharmaceutical services company. Dr Butler led Aptuit’s growth phase working to penetrate key North American, European and Asian markets, increase sales revenues from $75 million to over $200 million, as well as expand operations from three locations to eight sites globally.

Ian Buckley-Golder, chairman of Xceleron, said: “We are pleased to formally introduce Dr Michael Butler and announce this key appointment. Not only will this move strengthen Xceleron’s business operations, but the benefits derived across the organization from his leadership will be significant as the company drives revenue growth and expands its global footprint.”